The contribution of endogenous benzodiazepine receptor ligands to the pathogenesis of hepatic encephalopathy
- 1 February 1991
- Vol. 7 (2) , 141-150
- https://doi.org/10.1002/syn.890070208
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Increased brain uptake of γ-aminobutyric acid in a rabbit model of hepatic encephalopathyGastroenterology, 1990
- Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humansGastroenterology, 1989
- Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenilGastroenterology, 1989
- Detection and Characterization of Endogenous Benzodiazepine Activity in Both Animal Models and Humans with Hepatic EncephalopathyPublished by Springer Nature ,1989
- Evidence for the Involvement of the Benzodiazepine Receptor Complex in Hepatic Encephalopathy Implications for Treatment with Benzodiazepine Receptor AntagonistsClinical Neuropharmacology, 1988
- Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathyJournal of Neuroscience, 1988
- Brain γ-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma γ-aminobutyric acid-like activityGastroenterology, 1987
- Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failureGastroenterology, 1987
- Secondary Metabolism in Microorganisms, Plants and AnimalsPublished by Springer Nature ,1984
- A Rapid, Comprehensive Screening Procedure for Basic Drugs in Blood or Tissues by Gas ChromatographyJournal of Analytical Toxicology, 1978